T10	Treatment 140 158	TNF-alpha blockers
T12	Effect 169 201	cutaneous inflammatory reactions
T13	Severity_cue 6 22	mild to moderate
T15	Drug 140 158	TNF-alpha blockers
T17	Speculation_cue 127 136	potential
T18	Effect 23 56	application site reactions (ASRs)
T19	Treatment 112 121	imiquimod
T20	Drug 112 121	imiquimod
